Company: TELO
Filing Date: 2025-01-28
Form Type: 8-K
Source: 0001493152-25-003909
Chunk: 1

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-01-28
Form: 8-K
Item: Item 8.01
Chunk 1
---
 future results related to these matters may deviate
materially and adversely from the forward-looking statements contained herein. The Company does not assume any obligation to update forward-looking
statements as circumstances change, except as required by securities laws.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                                    TELOMIR                                       
  Dated:      January 28, 2025      By:                        /s/                
                                    Name:                      Erez               
                                    Title:                     Chief